Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-044168
Filing Date
2021-06-30
Accepted
2021-06-30 20:08:47
Documents
2
Period of Report
2021-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3959
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4606
  Complete submission text file 0001209191-21-044168.txt   9926
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Issuer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5425 WISCONSIN AVENUE SUITE 800 CHEVY CHASE MD 20815
Business Address
Nayeem Sara M. (Reporting) CIK: 0001709110 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39247 | Film No.: 211063530